Excess weight as a risk factor for kidney failure

Current Opinion in Nephrology and Hypertension

Volumn 16, Issue 2, 2007, Pages 71-76

  Nguyen, Stephanie ^a   Hsu, Chi Yuan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Albuminuria; Chronic kidney disease; End stage renal disease; Epidemiology; Obesity; Proteinuria

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TETRAHYDROLIPSTATIN;

BARIATRIC SURGERY; BODY MASS; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE COURSE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY FAILURE; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; WEIGHT REDUCTION;

BODY MASS INDEX; COHORT STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; OBESITY; RISK FACTORS; WEIGHT LOSS;

EID: 33846950082     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32802ef4b6     Document Type: Review

References (28)

1. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295:1549-1555.
2. Fox CS, Larson MG, Leip EP, et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291:844-850.
3. Kramer H, Luke A, Bidani A, et al. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am J Kidney Dis 2005; 46:587-594.
4. Gelber RP, Kurth T, Kausz AT, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 2005; 46:871-880.
5. 2 at age 20 was significantly associated with development of advanced chronic kidney disease. This was true even among those without diabetes or hypertension.
6. Brochner-Mortensen J, Rickers H, Balslev I. Renal function and body composition before and after intestinal bypass operation in obese patients. Scand J Clin Lab Invest 1980; 40:695-702.
7. Chertow GM, Hsu CY, Johansen KL. The enlarging body of evidence: obesity and chronic kidney disease. J Am Soc Nephrol 2006; 17:1501-1502.
8. Perry HM Jr, Miller JP, Fornoff JR, et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 1995; 25 (4 Pt 1):587-594.
9. Stengel B, Tarver-Carr ME, Powe NR, et al. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 2003; 14:479-487.
10. Iseki K, Ikemiya Y, Kinjo K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65:1870-1876.
11. 2 and persisted after adjustment for hypertension and diabetes.
12. Iseki K, Ikemiya Y, Fukiyama K. Predictors of end-stage renal disease and body mass index in a screened cohort. Kidney Int Suppl 1997; 63:S169-S170.
13. Dublin LI. Relation of obesity to longevity. N Engl J Med 1953; 248:971-974.
14. Dublin LI, Marks HH. Mortality among insured overweights in recent years. Trans Assoc Life Insur Med Dir Am 1951; 35:235-266.
15. Hsu CY, Feldman HI. Clinical research methods in CJASN. Clin J Am Soc Nephrol 2006; 1:1115-1116.
16. Thadhani R, Tonelli M. Cohort studies: marching forward. Clin J Am Soc Nephrol 2006; 1:1117-1123.
17. Cohen AH. Massive obesity and the kidney: a morphologic and statistical study. Am J Pathol 1975; 81:117-130.
18. Kasiske BL, Crosson JT. Renal disease in patients with massive obesity. Arch Intern Med 1986; 146:1105-1109.
19. Praga M, Hernandez E, Herrero JC, et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 2000; 58:2111-2118.
20. Praga M, Morales E. Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens 2006; 15:481-486.
21. Morales E, Valero M, León M, et al. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003; 41:319-327.
22. Praga M, Hernandez E, Andres A, et al. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 1995; 70:35-41.
23. Solerte SB, Fioravanti M, Schifino N, Ferrari E. Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy. Int J Obes 1989; 13:203-211.
24. Chagnac A, Weinstein T, Herman M, et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003; 14:1480-1486.
25. Palomar R, Fernandez-Fresnedo G, Dominguez-Diez A, et al. Effects of weight loss after biliopancreatic diversion on metabolism and cardiovascular profile. Obes Surg 2005; 15:794-798.
26. Serra A, Granada ML, Romero R, et al. The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clin Nutr 2006; 25:400-408.
27. Stokholm KH, Hoilund-Carlsen PF, Brochner-Mortensen J. Glomerular filtration rate after jejunoileal bypass for obesity. Int J Obes 1981; 5:77-80.
28. Tong PC, Lee ZS, Sea MM, et al. The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes. Arch Intern Med 2002; 162:2428-2435.